Apop’s breakthrough CalRexin® technologies are transforming our knowledge of complex cell stress mechanisms associated with programmed cell death (PCD) and autophagy which are important for several significant diseases. We have launched a pipeline of proprietary novel imaging reagents to interrogate these mechanisms, to be followed by a range of emerging therapeutics and diagnostics products. All Apop products are based on our proprietary calcitonin receptor antibody technology, CalRexin®, that targets a novel extracellular marker of these complex processes, is accumulated into live stressed cells and so far is proven for detection of apoptosis and autophagy.

Apop Biosciences

Org chart

Teams

Offices

Apop Biosciences

Org chart

Teams

Offices

Related companies